EKF Diagnostics (LON:EKF) Announces Earnings Results

EKF Diagnostics (LON:EKF) released its earnings results on Tuesday. The company reported GBX 0.47 earnings per share for the quarter, Digital Look Earnings reports. EKF Diagnostics had a return on equity of 3.01% and a net margin of 4.12%.

EKF Diagnostics Stock Down 2.5%

LON EKF opened at GBX 23.60 on Thursday. The stock’s 50-day moving average price is GBX 25.69 and its 200-day moving average price is GBX 26.38. The company has a quick ratio of 1.77, a current ratio of 4.16 and a debt-to-equity ratio of 2.01. EKF Diagnostics has a 52 week low of GBX 19 and a 52 week high of GBX 32. The company has a market capitalization of £101.91 million, a P/E ratio of 17.48 and a beta of 0.53.

About EKF Diagnostics

EKF is an AIM-listed global diagnostics business focussed on:

● Point-of-Care analysers in the key areas of Hematology and Diabetes

● Life Sciences services provide specialist manufacture of enzymes and custom products for use in diagnostic, food and industrial applications.

EKF has headquarters in Penarth (near Cardiff) and operates five manufacturing sites across the US and Germany, selling into over 120 countries world-wide.